A 50 years old male with type 2 diabetes mellitus is found to have 24 hour urinary albumin of 250 mg. Which of the following drugs may be used to retard progression of renal disease ?
First, I need to recall the core concept here. Diabetic nephropathy is a common complication of diabetes, leading to kidney damage. The key is to identify the class of drugs that are most effective in slowing this progression. The presence of albuminuria indicates early kidney damage, so the right medication should address that.
The correct answer is likely an ACE inhibitor or an ARB. Both are known for their renoprotective effects. They reduce glomerular pressure, decrease proteinuria, and slow the progression of kidney disease in diabetic patients. The specific drug from these classes would depend on the options provided, but since the options here are labeled A-D without names, I have to assume that one of them is an ACE inhibitor or ARB.
Now, why are other options incorrect? For example, if one of the options is a diuretic like thiazide, those are not the first-line for diabetic nephropathy. Diuretics might be used for hypertension but don't have the same renoprotective effects. Beta-blockers could be another distractor; they lower blood pressure but aren't as effective in reducing proteinuria as ACE inhibitors or ARBs. Calcium channel blockers (CCBs) might lower blood pressure but again, not as effective in this context.
The clinical pearl here is that for diabetic patients with albuminuria, ACE inhibitors or ARBs are the drugs of choice. They not only manage hypertension but also provide renal protection. The student should remember that these drugs are pivotal in slowing the progression of diabetic nephropathy.
Wait, the user's correct answer wasn't provided in the options. Let me check the original question again. Oh, the options are labeled A-D but the correct answer's letter isn't specified here. However, based on standard guidelines, the correct drug would be an ACE inhibitor or ARB. So if the options include such a drug, that's the answer. The user's correct answer is probably labeled as one of these options, but since the options are missing, I'll proceed with the explanation focusing on the mechanism and why other classes are less effective.
Also, the urinary albumin of 250 mg is significant, indicating microalbuminuria or macroalbuminuria. Either way, the approach is the same. The key is to address both blood pressure and proteinuria, which ACE inhibitors and ARBs do effectively.
So, in the explanation, I need to emphasize the renoprotective mechanisms of ACE/ARBs, contrast them with other drug classes, and highlight the clinical pearl about their use in diabetic nephropathy.
**Core Concept**
In diabetic nephropathy, **ACE inhibitors** and **ARBs** are first-line therapies to reduce glomerular hyperfiltration and proteinuria. They inhibit the renin-angiotensin-aldosterone system (RAAS), which is hyperactivated in diabetic kidney disease, thereby slowing progression to end-stage renal disease (ESRD).
**Why the Correct Answer is Right**
ACE inhibitors (e.g., enalapril) or ARBs (e.g., losartan) reduce intraglomerular